The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Edluar 5 mg sublingual tablets



Mylan IRE Healthcare LimitedPA2010/050/001

Main Information

Trade NameEdluar 5 mg sublingual tablets
Active SubstancesZolpidem tartrate
Dosage FormSublingual tablet
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/050/001

Group Information

ATC CodeN05CF Benzodiazepine related drugs
N05CF02 zolpidem

Status

License statusAuthorised
Licence Issued24/09/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back